Literature DB >> 20203001

Rare sequence variation in the genome flanking a short tandem repeat locus can lead to a question of "nonmaternity".

Anne Deucher1, Tsoyu Chiang, Iris Schrijver.   

Abstract

Typing of STR (short tandem repeat) alleles is used in a variety of applications in clinical molecular pathology, including evaluations for maternal cell contamination. Using a commercially available STR typing assay for maternal cell contamination performed in conjunction with prenatal diagnostic testing, we were posed with apparent nonmaternity when the two fetal samples did not demonstrate the expected maternal allele at one locus. By designing primers external to the region amplified by the primers from the commercial assay and by performing direct sequencing of the resulting amplicon, we were able to determine that a guanine to adenine sequence variation led to primer mismatch and allele dropout. This explained the apparent null allele shared between the maternal and fetal samples. Therefore, although rare, allele dropout must be considered whenever unexplained homozygosity at an STR locus is observed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20203001      PMCID: PMC2860477          DOI: 10.2353/jmoldx.2010.090201

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  18 in total

1.  Non-amplification of an allele of the D8S1179 locus due to a point mutation.

Authors:  G R Han; E S Song; J J Hwang
Journal:  Int J Legal Med       Date:  2001-08       Impact factor: 2.686

2.  Identification of a D8S1179 primer binding site mutation and the validation of a primer designed to recover null alleles.

Authors:  Craig Leibelt; Bruce Budowle; Patrick Collins; Yasser Daoudi; Tamyra Moretti; Gary Nunn; Dennis Reeder; Rhonda Roby
Journal:  Forensic Sci Int       Date:  2003-05-05       Impact factor: 2.395

3.  False homozygosities at various loci revealed by discrepancies between commercial kits: implications for genetic databases.

Authors:  Magali Delamoye; Charlotte Duverneuil; Katia Riva; Michel Leterreux; Stéphane Taieb; Philippe De Mazancourt
Journal:  Forensic Sci Int       Date:  2004-06-30       Impact factor: 2.395

4.  Contribution for an African autosomic STR database (AmpF/STR Identifiler and Powerplex 16 System) and a report on genotypic variations.

Authors:  Cíntia Alves; Leonor Gusmão; Albertino Damasceno; Benilde Soares; António Amorim
Journal:  Forensic Sci Int       Date:  2004-01-28       Impact factor: 2.395

5.  Comparison between DNA melting thermodynamics and DNA polymerase fidelity.

Authors:  J Petruska; M F Goodman; M S Boosalis; L C Sowers; C Cheong; I Tinoco
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

6.  Automated DNA profiling employing multiplex amplification of short tandem repeat loci.

Authors:  C P Kimpton; P Gill; A Walton; A Urquhart; E S Millican; M Adams
Journal:  PCR Methods Appl       Date:  1993-08

7.  Evaluation of 13 short tandem repeat loci for use in personal identification applications.

Authors:  H A Hammond; L Jin; Y Zhong; C T Caskey; R Chakraborty
Journal:  Am J Hum Genet       Date:  1994-07       Impact factor: 11.025

8.  General concepts for PCR primer design.

Authors:  C W Dieffenbach; T M Lowe; G S Dveksler
Journal:  PCR Methods Appl       Date:  1993-12

Review 9.  Complex and segmental uniparental disomy updated.

Authors:  D Kotzot
Journal:  J Med Genet       Date:  2008-06-04       Impact factor: 6.318

10.  Primer binding site mutations affecting the typing of STR loci contained within the AMPFlSTR SGM Plus kit.

Authors:  T M Clayton; S M Hill; L A Denton; S K Watson; A J Urquhart
Journal:  Forensic Sci Int       Date:  2004-01-28       Impact factor: 2.395

View more
  1 in total

1.  Laboratory guidelines for detection, interpretation, and reporting of maternal cell contamination in prenatal analyses a report of the association for molecular pathology.

Authors:  Narasimhan Nagan; Nicole E Faulkner; Christine Curtis; Iris Schrijver
Journal:  J Mol Diagn       Date:  2010-12-23       Impact factor: 5.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.